| |
| |
|
| Insider
Information: |
Darecca James |
| Relationship: |
Director |
| City: |
Parsippany |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
140,227 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,675,193 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
140,227 |
|
|
| Total
Value |
$1,675,193 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -79.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Allergan plc |
AGN |
SVP Chief Accounting O... |
2020-05-08 |
0 |
2014-05-09 |
0 |
Premium* |
|
|
Therapeuticsmd Inc |
TXMD |
Chief Financial Officer |
2021-08-12 |
123,830 |
2021-08-10 |
0 |
Premium* |
|
|
Haemonetics Corp |
HAE |
EVP, Chief Financial O... |
2023-05-16 |
14,102 |
2022-05-02 |
0 |
Premium* |
|
|
Prestige Brands Holdings Inc |
PBH |
Director |
2023-08-01 |
2,295 |
2023-08-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PBH |
Prestige Brands Holdings ... |
Director |
– • – |
2023-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,295 |
2,295 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2023-05-16 |
4 |
D |
$89.21 |
$31,134 |
D/D |
(349) |
14,102 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2023-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
4,205 |
14,451 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2023-05-02 |
4 |
D |
$81.66 |
$35,114 |
D/D |
(430) |
10,246 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2022-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
4,774 |
10,676 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2022-05-02 |
4 |
A |
$0.00 |
$0 |
D/D |
5,902 |
5,902 |
0 |
- |
|
| TXMD |
Therapeuticsmd Inc |
Chief Financial Officer |
• – – |
2021-08-12 |
4 |
S |
$0.87 |
$81,203 |
D/D |
(93,337) |
123,830 |
0 |
% |
|
| TXMD |
Therapeuticsmd Inc |
Chief Financial Officer |
• – – |
2021-08-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
217,167 |
217,167 |
0 |
- |
|
| AGN |
Allergan plc |
SVP Chief Accounting Officer |
• – – |
2020-05-08 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,511) |
0 |
0 |
- |
|
| AGN |
Allergan plc |
SVP Chief Accounting Officer |
• – – |
2020-05-08 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,324) |
0 |
0 |
- |
|
| AGN |
Allergan plc |
SVP Chief Accounting Officer |
• – – |
2020-03-06 |
4 |
D |
$191.95 |
$137,820 |
D/D |
(718) |
9,834 |
0 |
- |
|
| AGN |
Allergan plc |
SVP Chief Accounting Officer |
• – – |
2020-03-02 |
4 |
A |
$193.84 |
$699,956 |
D/D |
3,611 |
10,552 |
0 |
- |
|
| AGN |
Allergan plc |
SVP Chief Accounting Officer |
• – – |
2019-12-31 |
4 |
D |
$191.17 |
$17,588 |
D/D |
(92) |
6,941 |
0 |
- |
|
| AGN |
Allergan plc |
SVP Chief Accounting Officer |
• – – |
2019-03-08 |
4 |
D |
$145.06 |
$16,392 |
D/D |
(113) |
7,033 |
0 |
- |
|
| AGN |
Allergan plc |
SVP Chief Accounting Officer |
• – – |
2019-03-07 |
4 |
D |
$143.00 |
$51,337 |
D/D |
(359) |
7,146 |
0 |
- |
|
| AGN |
Allergan plc |
SVP Chief Accounting Officer |
• – – |
2019-03-06 |
4 |
A |
$137.51 |
$279,970 |
D/D |
2,036 |
7,505 |
0 |
- |
|
| AGN |
Allergan plc |
SVP Chief Accounting Officer |
• – – |
2019-03-04 |
4 |
D |
$139.12 |
$15,860 |
D/D |
(114) |
5,469 |
0 |
- |
|
| AGN |
Allergan plc |
SVP Chief Accounting Officer |
• – – |
2018-12-31 |
4 |
D |
$133.66 |
$19,648 |
D/D |
(147) |
5,453 |
0 |
- |
|
| AGN |
Allergan plc |
Chief Accounting Officer |
• – – |
2018-03-08 |
4 |
D |
$153.50 |
$12,127 |
D/D |
(79) |
5,600 |
0 |
- |
|
| AGN |
Allergan plc |
Chief Accounting Officer |
• – – |
2018-03-07 |
4 |
A |
$153.22 |
$259,861 |
D/D |
1,696 |
5,679 |
0 |
- |
|
| AGN |
Allergan plc |
Chief Accounting Officer |
• – – |
2018-03-07 |
4/A |
A |
$153.22 |
$279,780 |
D/D |
1,826 |
5,809 |
0 |
- |
|
| AGN |
Allergan plc |
Chief Accounting Officer |
• – – |
2018-03-07 |
4 |
D |
$153.22 |
$14,249 |
D/D |
(93) |
3,983 |
0 |
- |
|
| AGN |
Allergan plc |
Chief Accounting Officer |
• – – |
2018-03-05 |
4 |
D |
$148.73 |
$10,411 |
D/D |
(70) |
4,076 |
0 |
- |
|
| AGN |
Allergan plc |
Chief Accounting Officer |
• – – |
2018-03-02 |
4 |
D |
$144.02 |
$10,946 |
D/D |
(76) |
4,146 |
0 |
- |
|
| AGN |
Allergan plc |
CHIEF ACCOUNTING OFFICER |
• – – |
2017-12-29 |
4 |
D |
$163.58 |
$16,358 |
D/D |
(100) |
4,222 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
